天元醫療:年報2023
Tianyuan Healthcare (00557.HK): Net loss of HK$15.484 million in 2023
On March 26, GLONGHUI | Tianyuan Healthcare (00557.HK) announced that for the year ended December 31, 2023, the turnover was approximately HK$45.23 million, a year-on-year decrease of 16.6%; the loss attributable to the company's equity holders was approximately HK$15.484 million; the loss attributable to the company's equity holders during the same period last year was approximately HK$29.36 million; basic loss per share.
Tianyuan Healthcare (00557) announced annual results. Shareholders should account for a loss of HK$15.484 million, a year-on-year decrease of 46.67%
Tianyuan Healthcare (00557) announced its annual results for the year ended December 31, 2023, with a turnover of 45.23 million HKD...
TIANYUAN HEALTH: 2023 FINAL RESULTS - ANNOUNCEMENT AUDITED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Tianyuan Healthcare (00557.HK) plans to hold a board meeting on March 26 to consider and approve the annual results
Gelonghui, March 12, 丨 Tianyuan Healthcare (00557.HK) announced that the board of directors of the company will meet at 4 p.m. on March 26, 2024 (Tuesday) to review and approve the Group's audited annual results for the year ended 31 December 2023 and their publication, as well as consider the payment of a final dividend (if any).
TIANYUAN HEALTH: 2023 Interim Financial Report
Tianyuan Healthcare (00557) released interim results. Shareholders' share of loss was HK$6.57 million, which narrowed by 64.6% year-on-year
Tianyuan Healthcare (00557) announced the results for the six months ended June 30, 2023, with a turnover of 2376.8...
TIANYUAN HEALTH: 2023 INTERIM RESULTS - ANNOUNCEMENT UNAUDITED CONSOLIDATED RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Tianyuan Medical (00557.HK) plans to hold a board meeting on August 30 to approve interim results
Glonway August 2, 丨Tianyuan Healthcare (00557.HK) announced that the company's board of directors will hold a meeting at 4:00 p.m. on August 30, 2023 (Wednesday) to review and approve (among others) the Group's unaudited interim results and publication for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
TIANYUAN HEALTH: NOTIFICATION OF BOARD MEETING
Tianyuan Healthcare: Annual Report 2022
Tianyuan Healthcare (00557.HK) expanded its annual net loss to HK$29.036 million
Gelonghui, March 30, 丨 Tianyuan Healthcare (00557.HK) announced that for the year ending December 31, 2022, the turnover was HK$54.216 million, a decrease of 42.68% over the previous year; the loss attributable to corporate equity holders during the year was HK$29.036 million. The loss for the same period last year was HK$168.54 million, with a basic loss of HK$7.28 per share. The higher net loss was mainly due to the negative impact of the novel coronavirus, which reduced the turnover of Shanghai hospitals, leading to higher net losses.
Tianyuan Healthcare: 2022 Final Results - Announced FOR THE YEAR ENDED DECEMBER 31, 2022 Audited comprehensive performance
Tianyuan Healthcare (00557.HK) will hold a board meeting on March 30 to approve annual results
Gelonghui, March 17, 丨 Tianyuan Healthcare (00557.HK) announced that the board of directors of the company will hold a meeting on March 30, 2023 to review and approve the Group's audited annual results for the year ending December 31, 2022 and their publication, and to consider the payment of interim and final dividends (if any).
Tianyuan Medical (00557): Dongwei was appointed as acting Chairman of the Board and member of the nomination Committee.
Zhitong Financial APP News, Tianyuan Medical (00557) issued an announcement that since November 4, 2022, the board of directors has approved Wang Huabing's resignation as executive director, chairman of the board, member of the nomination committee and authorized representative; and Dongwei has been appointed as acting chairman of the board of directors and member of the nomination committee.
Tianyuan Medical: interim Financial report 2022
Tianyuan Medical (00557.HK) lost about HK $18.538 million in the first half of the year.
00557.HK announced its interim results on August 30. For the six months ended June 30, 2022, the company's turnover was HK $24.984 million, down 48.42% from the same period last year. The loss attributable to the company's equity holders during the period was HK $18.538 million, compared with a loss of HK $6.137 million in the same period last year, or 4.64 cents per share.
Tianyuan Medical: interim results 2022-announcement Unaudited consolidated results for the six months ended June 30, 2022
Tianyuan Medical (00557.HK) plans to hold a board meeting on August 30th to approve interim results
00557.HK announced that the board of directors will meet on Tuesday, August 30th, 2022 at 04:00 to, among other things, review and approve the unaudited interim results and publication of the Group for the six months ended June 30th, 2022, and consider paying an interim dividend, if any.
Tianyuan Medical (00557.HK) appoints Li Jun as independent non-executive director
According to the announcement of 00557.HK, Mr. Guo Jingbin has resigned as an independent non-executive director, a member of the nomination Committee, the Chairman of the Remuneration Committee and a member of the Audit Committee; and Mr. Li Jun has been appointed as an independent non-executive Director, a member of the nomination Committee, the Chairman of the Remuneration Committee and a member of the Audit Committee with effect from 15 July 2022.
No Data